Start in 15/10/2010
launch of the company with a capital of 1.5 million euros
Artialis extents the scope of its ISO9001 to all its activities including the manufacturing of kits
own preclinical technological platform ; compliant with the ISO13485, manufacturing of ELISA kits
consortium agreement with ATC pharma, conducting early phase clinical trials as first-in-man studies
signing of a partnership agreement with In Clinical to promote its business in US and to operate WW
to be continued ...